Rantum Private Debt Fund III provides senior secured term loan to a German specialty pharmaceuticals company

Rantum Private Debt Fund III has provided a senior secured term loan to a German specialty pharmaceuticals company. The borrower is a leading provider of subscription drugs for the treatment of a specific group of illnesses. The company’s products are established in the market for many years and well-respected by doctors for their efficiency and safety.

Marc Pahlow, Managing Director at Rantum Capital, commented: “Rantum is pleased to provide a senior secured term loan to this market leading and very profitable pharmaceuticals company. It marks the fourth pharma transaction we have completed in the past two years. We are excited to support the company on its continued growth path.”